Figure 1From: Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer Median urologist rate of androgen deprivation (ADT) for inappropriate indications, based on the multilevel model from Table 2 , by calendar year of diagnosis and stratified by urologists with academic (major or minor) versus no academic affiliation. Back to article page